Your browser doesn't support javascript.
loading
Therapeutic antibodies - natural and pathological barriers and strategies to overcome them.
Al Ojaimi, Yara; Blin, Timothée; Lamamy, Juliette; Gracia, Matthieu; Pitiot, Aubin; Denevault-Sabourin, Caroline; Joubert, Nicolas; Pouget, Jean-Pierre; Gouilleux-Gruart, Valérie; Heuzé-Vourc'h, Nathalie; Lanznaster, Débora; Poty, Sophie; Sécher, Thomas.
Afiliação
  • Al Ojaimi Y; UMR 1253, iBrain, Inserm, 37000 Tours, France; University of Tours, 37000 Tours, France.
  • Blin T; University of Tours, 37000 Tours, France; UMR 1100, CEPR, Inserm, 37000 Tours, France.
  • Lamamy J; University of Tours, 37000 Tours, France; GICC, EA7501, 37000 Tours, France.
  • Gracia M; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier (ICM), Montpellier F-34298, France.
  • Pitiot A; University of Tours, 37000 Tours, France; UMR 1100, CEPR, Inserm, 37000 Tours, France.
  • Denevault-Sabourin C; University of Tours, 37000 Tours, France; GICC, EA7501, 37000 Tours, France.
  • Joubert N; University of Tours, 37000 Tours, France; GICC, EA7501, 37000 Tours, France.
  • Pouget JP; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier (ICM), Montpellier F-34298, France.
  • Gouilleux-Gruart V; University of Tours, 37000 Tours, France; GICC, EA7501, 37000 Tours, France.
  • Heuzé-Vourc'h N; University of Tours, 37000 Tours, France; UMR 1100, CEPR, Inserm, 37000 Tours, France. Electronic address: nathalie.vourch@med.univ-tours.fr.
  • Lanznaster D; UMR 1253, iBrain, Inserm, 37000 Tours, France; University of Tours, 37000 Tours, France.
  • Poty S; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier (ICM), Montpellier F-34298, France.
  • Sécher T; University of Tours, 37000 Tours, France; UMR 1100, CEPR, Inserm, 37000 Tours, France.
Pharmacol Ther ; 233: 108022, 2022 05.
Article em En | MEDLINE | ID: mdl-34687769

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article